Monitor for the execution of this sale (Form 4 filing) over the coming weeks. The dollar amount is modest relative to market cap and liquidity — unlikely to meaningfully pressure the stock. The director is simply monetizing option exercises in a routine manner. No earnings or catalyst event is imminent based on this filing.
Price Chart
Executive Summary
Director Andrew J. Fromkin filed a Form 144 on May 28, 2026, indicating intent to sell up to 221,951 shares of Immunovant common stock (approx. $7.4M at recent prices, ~0.11% of market cap). The shares were acquired primarily via stock option exercises and open-market purchases from 2021-2026, and are being sold through a broker at current market prices. The filing is routine for a director monetizing exercised options and does not suggest material company-specific concerns.
Key Facts
- Form 144 filed May 28, 2026 by director Andrew J. Fromkin
- Proposed sale of 221,951 shares of common stock
- Estimated aggregate value ~$7.44M based on ~$33.50 implied price (derived from stated $7.44M / 221,951 shares)
- Shares acquired via multiple option exercises and RSU vesting events between 2021 and 2026
- Sale not yet executed — Form 144 is an advance notice of intent to sell
- Market cap ~$6.7B; proposed sale represents ~0.0033% of shares outstanding
- Recent insider activity shows 3 prior sells totaling $574K in the last 30 days
Financial Impact
$7.44 million in potential selling proceeds, a minor fraction of $6.7B market cap
Risk Factors
- Insider selling could be interpreted negatively by the market, though the amount is very small relative to total shares outstanding
- The proposed sale has not been executed; market conditions or blackout periods could prevent it
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005198 |
| Document: 0001950047-26-005198-index.html | 0001950047-26-005198 |
| Document: 0001950047-26-005198.txt | 0001950047-26-005198 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | 8-K | $39.74 $39.12 | ▲ +1.56% | ▲ +2.16% | $27.68 (+30.35%) |
Jul 24, 2026 13w ago | Insider Cluster | $40.09 $43.32 | ▲ +8.06% | ▲ +4.76% | $27.68 (−30.96%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 15, 2026 18w ago | 144 | $33.61 $38.77 | ▲ +15.35% | ▲ +15.15% | $27.68 (−17.64%) |
May 28, 2026 21w ago | 144 | $33.30 $38.51 | ▲ +15.65% | ▲ +17.44% | $27.68 (−16.88%) |
May 20, 2026 22w ago | 8-K | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
May 20, 2026 22w ago | Press Release | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers